Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Clinical trial NCT00823368 · COMPLETED

Trial details

NCT number: NCT00823368
Sponsor: Seaside Therapeutics, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Fragile X Syndrome

Start date: 2009-01-01
Primary completion: 2010-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.